Info
Cost containment and efficiency in national health systems [[electronic resource] ] : a global comparison / / edited by John Rapoport, Philip Jacobs, and Egon Jonsson
| Cost containment and efficiency in national health systems [[electronic resource] ] : a global comparison / / edited by John Rapoport, Philip Jacobs, and Egon Jonsson |
| Pubbl/distr/stampa | Weinheim, : Wiley-Blackwell, c2009 |
| Descrizione fisica | 1 online resource (249 p.) |
| Disciplina | 362.1 |
| Altri autori (Persone) |
JacobsPhilip <1943->
JonssonEgon RapoportJohn <1944-> |
| Collana | Health care and disease management |
| Soggetto topico |
Health services administration - Finance
Medical policy |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-02132-X
9786612021329 3-527-62296-9 3-527-62295-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cost Containment and Efficiency in National Health Systems: A Global Comparison; Contents; Preface; List of Contributors; 1 Introduction and Summary; 1.1 Introduction; 1.2 Highlights of Each Country's Approach; 1.3 How Are Cost Containment and Efficiency Related?; 1.4 Strategies and Their Effects: A Cross-Country Analysis; 1.5 Current Policy Agenda; References; 2 Canada; 2.1 Canada's Health Care System; 2.1.1 Paying for Canadian Health Care; 2.1.2 Delivering Health Care in Canada; 2.1.3 Overall Expenditure Trends; 2.1.4 Cost Control Strategies Employed; 2.2 Supply-Side Measures
2.2.1 Capped Budgets2.2.1.1 Hospitals; 2.2.1.2 Physicians; 2.2.1.3 Pharmaceuticals; 2.2.2 Health Human Resource Limits; 2.2.2.1 Physicians; 2.2.2.2 Other Health Care Professionals; 2.3 Organizational Reforms: Trade-Offs Between Competition and Cooperation; 2.3.1 Cooperation: Regional Authorities; 2.3.2 Cooperation: Primary Care Reform; 2.3.3 Waiting Time Strategies; 2.3.4 Competition; 2.4 Demand-Side Measures; 2.4.1 Technology Assessment/Appropriateness; 2.4.2 Population Health; 2.5 The Current Situation; References; 3 England; 3.1 Introduction; 3.2 The Structural Characteristics of the NHS 3.3 The Efficiency Initiatives3.3.1 The Internal Market; 3.3.2 The National Institute for Health and Clinical Excellence; 3.3.3 Performance Management; 3.3.4 Patient Choice; 3.4 Conclusions; References; 4 Finland; 4.1 Introduction; 4.2 The Finnish Health Care System; 4.2.1 Structure; 4.2.2 Trends in Cost and Financing; 4.3 Strategies for Municipal Health Services; 4.3.1 Decentralization of Responsibilities; 4.3.2 Governments Strategic Planning; 4.3.3 Cost Containment at the Local Level; 4.3.4 Increasing the Size of Municipalities; 4.3.5 Evaluation of the Strategies 4.4 Cost Containment in Services Covered by NHI4.4.1 The Finnish Pharmaceutical System; 4.4.2 Cost-Containment Measures; 4.4.2.1 Cost Sharing and Price Control; 4.4.2.2 Generic Substitution; 4.4.2.3 Other Measures; 4.4.3 Evaluation of Strategies; 4.4.3.1 Total Expenditure on Drugs; 4.4.3.2 Development of Prices; 4.4.3.3 The Effect of Generic Substitution; 4.5 Lessons from Finland; References; 5 Germany; 5.1 A Review of the Major Structural and Operational Characteristics of the German Health Care System; 5.1.1 Key Aspects of Sickness Funds and Providers of Health Care 5.1.2 Key Aspects on Financing of Health Care5.2 Major Cost-Containment and Efficiency-Seeking Strategies; 5.2.1 Global Budgets and Spending Caps; 5.2.1.1 Pharmaceuticals; 5.2.1.2 Ambulatory Care; 5.2.1.3 Hospital Care; 5.2.1.4 Financial and Other Performance Indicators of SHI Ambulatory Physician Practices and Hospitals; 5.2.2 Cost Shifts to Private Households; 5.2.3 Promoting Competition between Sickness Funds and Providers; 5.2.4 Strengthening the Competencies of Joint Self-Government; 5.2.5 Summarizing and Concluding Remarks on Cost Containment and Efciency Seeking Strategies 5.3 Report on the Current Situation |
| Record Nr. | UNINA-9910145257003321 |
| Weinheim, : Wiley-Blackwell, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cost containment and efficiency in national health systems [[electronic resource] ] : a global comparison / / edited by John Rapoport, Philip Jacobs, and Egon Jonsson
| Cost containment and efficiency in national health systems [[electronic resource] ] : a global comparison / / edited by John Rapoport, Philip Jacobs, and Egon Jonsson |
| Pubbl/distr/stampa | Weinheim, : Wiley-Blackwell, c2009 |
| Descrizione fisica | 1 online resource (249 p.) |
| Disciplina | 362.1 |
| Altri autori (Persone) |
JacobsPhilip <1943->
JonssonEgon RapoportJohn <1944-> |
| Collana | Health care and disease management |
| Soggetto topico |
Health services administration - Finance
Medical policy |
| ISBN |
1-282-02132-X
9786612021329 3-527-62296-9 3-527-62295-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cost Containment and Efficiency in National Health Systems: A Global Comparison; Contents; Preface; List of Contributors; 1 Introduction and Summary; 1.1 Introduction; 1.2 Highlights of Each Country's Approach; 1.3 How Are Cost Containment and Efficiency Related?; 1.4 Strategies and Their Effects: A Cross-Country Analysis; 1.5 Current Policy Agenda; References; 2 Canada; 2.1 Canada's Health Care System; 2.1.1 Paying for Canadian Health Care; 2.1.2 Delivering Health Care in Canada; 2.1.3 Overall Expenditure Trends; 2.1.4 Cost Control Strategies Employed; 2.2 Supply-Side Measures
2.2.1 Capped Budgets2.2.1.1 Hospitals; 2.2.1.2 Physicians; 2.2.1.3 Pharmaceuticals; 2.2.2 Health Human Resource Limits; 2.2.2.1 Physicians; 2.2.2.2 Other Health Care Professionals; 2.3 Organizational Reforms: Trade-Offs Between Competition and Cooperation; 2.3.1 Cooperation: Regional Authorities; 2.3.2 Cooperation: Primary Care Reform; 2.3.3 Waiting Time Strategies; 2.3.4 Competition; 2.4 Demand-Side Measures; 2.4.1 Technology Assessment/Appropriateness; 2.4.2 Population Health; 2.5 The Current Situation; References; 3 England; 3.1 Introduction; 3.2 The Structural Characteristics of the NHS 3.3 The Efficiency Initiatives3.3.1 The Internal Market; 3.3.2 The National Institute for Health and Clinical Excellence; 3.3.3 Performance Management; 3.3.4 Patient Choice; 3.4 Conclusions; References; 4 Finland; 4.1 Introduction; 4.2 The Finnish Health Care System; 4.2.1 Structure; 4.2.2 Trends in Cost and Financing; 4.3 Strategies for Municipal Health Services; 4.3.1 Decentralization of Responsibilities; 4.3.2 Governments Strategic Planning; 4.3.3 Cost Containment at the Local Level; 4.3.4 Increasing the Size of Municipalities; 4.3.5 Evaluation of the Strategies 4.4 Cost Containment in Services Covered by NHI4.4.1 The Finnish Pharmaceutical System; 4.4.2 Cost-Containment Measures; 4.4.2.1 Cost Sharing and Price Control; 4.4.2.2 Generic Substitution; 4.4.2.3 Other Measures; 4.4.3 Evaluation of Strategies; 4.4.3.1 Total Expenditure on Drugs; 4.4.3.2 Development of Prices; 4.4.3.3 The Effect of Generic Substitution; 4.5 Lessons from Finland; References; 5 Germany; 5.1 A Review of the Major Structural and Operational Characteristics of the German Health Care System; 5.1.1 Key Aspects of Sickness Funds and Providers of Health Care 5.1.2 Key Aspects on Financing of Health Care5.2 Major Cost-Containment and Efficiency-Seeking Strategies; 5.2.1 Global Budgets and Spending Caps; 5.2.1.1 Pharmaceuticals; 5.2.1.2 Ambulatory Care; 5.2.1.3 Hospital Care; 5.2.1.4 Financial and Other Performance Indicators of SHI Ambulatory Physician Practices and Hospitals; 5.2.2 Cost Shifts to Private Households; 5.2.3 Promoting Competition between Sickness Funds and Providers; 5.2.4 Strengthening the Competencies of Joint Self-Government; 5.2.5 Summarizing and Concluding Remarks on Cost Containment and Efciency Seeking Strategies 5.3 Report on the Current Situation |
| Record Nr. | UNINA-9910829935303321 |
| Weinheim, : Wiley-Blackwell, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cost containment and efficiency in national health systems : a global comparison / / edited by John Rapoport, Philip Jacobs, and Egon Jonsson
| Cost containment and efficiency in national health systems : a global comparison / / edited by John Rapoport, Philip Jacobs, and Egon Jonsson |
| Pubbl/distr/stampa | Weinheim, : Wiley-Blackwell, c2009 |
| Descrizione fisica | 1 online resource (249 p.) |
| Disciplina | 362.1 |
| Altri autori (Persone) |
JacobsPhilip <1943->
JonssonEgon RapoportJohn <1944-> |
| Collana | Health care and disease management |
| Soggetto topico |
Health services administration - Finance
Medical policy |
| ISBN |
9786612021329
9781282021327 128202132X 9783527622962 3527622969 9783527622955 3527622950 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cost Containment and Efficiency in National Health Systems: A Global Comparison; Contents; Preface; List of Contributors; 1 Introduction and Summary; 1.1 Introduction; 1.2 Highlights of Each Country's Approach; 1.3 How Are Cost Containment and Efficiency Related?; 1.4 Strategies and Their Effects: A Cross-Country Analysis; 1.5 Current Policy Agenda; References; 2 Canada; 2.1 Canada's Health Care System; 2.1.1 Paying for Canadian Health Care; 2.1.2 Delivering Health Care in Canada; 2.1.3 Overall Expenditure Trends; 2.1.4 Cost Control Strategies Employed; 2.2 Supply-Side Measures
2.2.1 Capped Budgets2.2.1.1 Hospitals; 2.2.1.2 Physicians; 2.2.1.3 Pharmaceuticals; 2.2.2 Health Human Resource Limits; 2.2.2.1 Physicians; 2.2.2.2 Other Health Care Professionals; 2.3 Organizational Reforms: Trade-Offs Between Competition and Cooperation; 2.3.1 Cooperation: Regional Authorities; 2.3.2 Cooperation: Primary Care Reform; 2.3.3 Waiting Time Strategies; 2.3.4 Competition; 2.4 Demand-Side Measures; 2.4.1 Technology Assessment/Appropriateness; 2.4.2 Population Health; 2.5 The Current Situation; References; 3 England; 3.1 Introduction; 3.2 The Structural Characteristics of the NHS 3.3 The Efficiency Initiatives3.3.1 The Internal Market; 3.3.2 The National Institute for Health and Clinical Excellence; 3.3.3 Performance Management; 3.3.4 Patient Choice; 3.4 Conclusions; References; 4 Finland; 4.1 Introduction; 4.2 The Finnish Health Care System; 4.2.1 Structure; 4.2.2 Trends in Cost and Financing; 4.3 Strategies for Municipal Health Services; 4.3.1 Decentralization of Responsibilities; 4.3.2 Governments Strategic Planning; 4.3.3 Cost Containment at the Local Level; 4.3.4 Increasing the Size of Municipalities; 4.3.5 Evaluation of the Strategies 4.4 Cost Containment in Services Covered by NHI4.4.1 The Finnish Pharmaceutical System; 4.4.2 Cost-Containment Measures; 4.4.2.1 Cost Sharing and Price Control; 4.4.2.2 Generic Substitution; 4.4.2.3 Other Measures; 4.4.3 Evaluation of Strategies; 4.4.3.1 Total Expenditure on Drugs; 4.4.3.2 Development of Prices; 4.4.3.3 The Effect of Generic Substitution; 4.5 Lessons from Finland; References; 5 Germany; 5.1 A Review of the Major Structural and Operational Characteristics of the German Health Care System; 5.1.1 Key Aspects of Sickness Funds and Providers of Health Care 5.1.2 Key Aspects on Financing of Health Care5.2 Major Cost-Containment and Efficiency-Seeking Strategies; 5.2.1 Global Budgets and Spending Caps; 5.2.1.1 Pharmaceuticals; 5.2.1.2 Ambulatory Care; 5.2.1.3 Hospital Care; 5.2.1.4 Financial and Other Performance Indicators of SHI Ambulatory Physician Practices and Hospitals; 5.2.2 Cost Shifts to Private Households; 5.2.3 Promoting Competition between Sickness Funds and Providers; 5.2.4 Strengthening the Competencies of Joint Self-Government; 5.2.5 Summarizing and Concluding Remarks on Cost Containment and Efciency Seeking Strategies 5.3 Report on the Current Situation |
| Record Nr. | UNINA-9911019311003321 |
| Weinheim, : Wiley-Blackwell, c2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Ethical and Legal Perspectives in Fetal Alcohol Spectrum Disorders (FASD) : Foundational Issues / / edited by Egon Jonsson, Sterling Clarren, Ian Binnie
| Ethical and Legal Perspectives in Fetal Alcohol Spectrum Disorders (FASD) : Foundational Issues / / edited by Egon Jonsson, Sterling Clarren, Ian Binnie |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (355 pages) : illustrations |
| Disciplina | 618.326861 |
| Collana | International Library of Ethics, Law, and the New Medicine |
| Soggetto topico |
Ethics
Criminology Criminal law Maternal and child health services Criminology and Criminal Justice, general Criminal Law and Criminal Procedure Law Maternal and Child Health |
| ISBN | 3-319-71755-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1: Overview -- FASD and Justice: An Historical Perspective; Kenneth R. Warren and Linda L. Chezem -- FASD and the Denial of Equality; Ian Binnie -- Prenatal Alcohol Exposure and Abnormal Brain Development –findings from basic research; Kathleen K. Sulik -- The Economics of FASD Associated with Crimes; Nguyen Xuan Thanh and Egon Jonsson -- Chapter 2: Definition and Identification of FAS -- Understanding the Methods for Diagnosing FASD; Sterling Clarren -- Imaging Brain Structure in FASD; Sarah Treit and Christian BeaulieuScreening and Assessment of FASD in a Youth Justice System: Comparing Different Methodologies; Deepa Singal, Teresa Brown, Sally Longstaffe, Mary Kate Harvie, Trevor Markesteyn, and Albert E. Chudley -- Chapter 3: Characteristics of People with FASD -- Social Incompetence of FASD Offenders: Risk-Awareness as a Factor in Criminal Culpability; Stephen Greenspan and George Woods -- Understanding the Neurobehavioral Deficits and Psycholegal Capacities of Individuals with FASD in the Criminal Justice System; Kaitlyn McLachlan and Carmen Rasmussen -- FASD in Adult Populations: Clinical and Forensic Considerations; Jerrod Brown, Nikki Freeman, Hal Pickett, Erin Watts, and Aaron Trnka -- Chapter 4: Sentencing and Support of People with FASD.-Introduction; FASD and the Revolving Door of Criminal Justice; Fia Jampolsky -- FASD and Competency to Stand Trial: An Exploratory Review; Jerrod Brown, Jeffrey Haun, Patricia A. Zapf, and Tricia Aiken -- Clinical and Ethical Issues when Completing Decision-Making Capacity Evaluations with People Diagnosed with FASD; Arlin Pachet and Avril J. Keller -- Legislative Impediments to Judicial Consideration of Moral Blameworthiness in Sentencing FASD Affected Offenders – a Canadian perspective; Jonathan Rudin -- FASD in a Youth Criminal Defense Office; Cathy Lane Goodfellow -- Chapter 5: Societal Issues -- Risk, Needs, Responsivity: Rethinking FASD in the Criminal Justice System; Jacqueline Pei and Andrew Burke -- FASD and Firesetting: An Exploratory Review; Jerrod Brown, Anthony P. Wartnik, Sarah Herrick, Kathi Osmonson, Margaret R. Wimberley, and Patricia Jones -- Appendix A: Consensus Statement on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) -- Editors and contributors. |
| Record Nr. | UNINA-9910300618203321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Financing health care : new ideas for a changing society / / edited by Mingshan Lu and Egon Jonsson
| Financing health care : new ideas for a changing society / / edited by Mingshan Lu and Egon Jonsson |
| Pubbl/distr/stampa | Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2008 |
| Descrizione fisica | 1 online resource (293 p.) |
| Disciplina | 362.10681 |
| Collana | Health Care and Disease Management |
| Soggetto topico |
Medical care - Canada - Finance
Medical care, Cost of - Canada Health insurance - Canada |
| ISBN |
1-282-11843-9
9786612118432 3-527-61129-0 3-527-61669-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Financing Health Care; Contents; Preface; List of Contributors; 1 Introduction; 1.1 Health Systems Reform; 1.2 Aging Populations and Advanced Medical Technology; 1.3 Decentralization; 1.4 The Content of this Book; References; 2 Social Health Insurance: Government Funding of Health Care; 2.1 Introduction; 2.2 Health Services, Health Insurance, and Market Failure; 2.3 Different Models for Government Funding of Health Care; 2.4 Conclusion: The Future of Social Health Insurance in Canada; References; 3 Private Financing Outside the Publicly Funded System
3.1 Introduction and the Evolution of Private Financing in Canada3.2 Reviewing Economic Theory and Evidence on Parallel Public and Private Financing Structures; 3.3 OECD Evidence on Private Financing; 3.4 Overall Conclusions and Directions for Further Study; References; 4 Prescription Drug Financing; 4.1 Introduction; 4.2 Drug Expenditures and Financing in Canada and Abroad; 4.3 Unique Aspects of Pharmaceuticals and the Pharmaceutical Sector; 4.4 Considerations for Pharmaceutical Financing Reform; 4.5 Conclusion; References; 5 The Economics of Consumer-Directed Health Care; 5.1 Introduction 5.2 Consumer-Preventive Care Decisions5.3 Selection and Cross-Subsidization; 5.4 Health Care Demand and Non-Linear Prices; 5.5 Empirical Studies of Consumer-Directed Health Care; 5.6 Conclusion; References; 6 Medical Savings Accounts: Promises and Pitfalls; 6.1 Introduction; 6.2 MSA Financing Internationally; 6.3 MSA Financing and System Performance; 6.4 Conclusions; References; 7 Physician Payment Mechanisms; 7.1 Introduction; 7.2 A Basic Model of Health-Care Provision and Consumption; 7.3 Traditional Fee-For-Service (FFS); 7.4 Capitation and Fully Prospective Payments 7.5 Mixed-Payment Systems7.6 Concluding Remarks; References and Footnotes; 8 Risk Adjustment in Health Care Markets: Concepts and Applications; 8.1 Overview; 8.2 Introduction; 8.3 Theory; 8.4 Estimation Issues; 8.5 Country Experience with Risk Adjustment; 8.6 Conclusions; References; 9 Inducing Quality from Health Care Providers in the Presence of Adverse Selection; 9.1 Introduction; 9.2 The Basic Adverse Selection Problem; 9.3 Dealing with Adverse Selection; 9.4 The Regulator Can Observe Quality, But Consumers Cannot: Choosing What to Report 9.5 Consumers Can Observe Quality and the Regulator Can Observe "Signals" About Consumers' Types: Risk Adjustment9.6 Concluding Remarks; References; 10 Equity in Health and Health Care in Canada in International Perspective; 10.1 Overview; 10.2 Introduction: Canada's Health Care System and Equity; 10.3 Income-Related Inequity in Access to, and Delivery of, Care; 10.4 Inequalities in Health and Health Outcomes; 10.5 Conclusion and Discussion; References; Index |
| Record Nr. | UNINA-9910144847603321 |
| Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Financing health care : new ideas for a changing society / / edited by Mingshan Lu and Egon Jonsson
| Financing health care : new ideas for a changing society / / edited by Mingshan Lu and Egon Jonsson |
| Pubbl/distr/stampa | Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2008 |
| Descrizione fisica | 1 online resource (293 p.) |
| Disciplina | 362.10681 |
| Collana | Health Care and Disease Management |
| Soggetto topico |
Medical care - Canada - Finance
Medical care, Cost of - Canada Health insurance - Canada |
| ISBN |
1-282-11843-9
9786612118432 3-527-61129-0 3-527-61669-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Financing Health Care; Contents; Preface; List of Contributors; 1 Introduction; 1.1 Health Systems Reform; 1.2 Aging Populations and Advanced Medical Technology; 1.3 Decentralization; 1.4 The Content of this Book; References; 2 Social Health Insurance: Government Funding of Health Care; 2.1 Introduction; 2.2 Health Services, Health Insurance, and Market Failure; 2.3 Different Models for Government Funding of Health Care; 2.4 Conclusion: The Future of Social Health Insurance in Canada; References; 3 Private Financing Outside the Publicly Funded System
3.1 Introduction and the Evolution of Private Financing in Canada3.2 Reviewing Economic Theory and Evidence on Parallel Public and Private Financing Structures; 3.3 OECD Evidence on Private Financing; 3.4 Overall Conclusions and Directions for Further Study; References; 4 Prescription Drug Financing; 4.1 Introduction; 4.2 Drug Expenditures and Financing in Canada and Abroad; 4.3 Unique Aspects of Pharmaceuticals and the Pharmaceutical Sector; 4.4 Considerations for Pharmaceutical Financing Reform; 4.5 Conclusion; References; 5 The Economics of Consumer-Directed Health Care; 5.1 Introduction 5.2 Consumer-Preventive Care Decisions5.3 Selection and Cross-Subsidization; 5.4 Health Care Demand and Non-Linear Prices; 5.5 Empirical Studies of Consumer-Directed Health Care; 5.6 Conclusion; References; 6 Medical Savings Accounts: Promises and Pitfalls; 6.1 Introduction; 6.2 MSA Financing Internationally; 6.3 MSA Financing and System Performance; 6.4 Conclusions; References; 7 Physician Payment Mechanisms; 7.1 Introduction; 7.2 A Basic Model of Health-Care Provision and Consumption; 7.3 Traditional Fee-For-Service (FFS); 7.4 Capitation and Fully Prospective Payments 7.5 Mixed-Payment Systems7.6 Concluding Remarks; References and Footnotes; 8 Risk Adjustment in Health Care Markets: Concepts and Applications; 8.1 Overview; 8.2 Introduction; 8.3 Theory; 8.4 Estimation Issues; 8.5 Country Experience with Risk Adjustment; 8.6 Conclusions; References; 9 Inducing Quality from Health Care Providers in the Presence of Adverse Selection; 9.1 Introduction; 9.2 The Basic Adverse Selection Problem; 9.3 Dealing with Adverse Selection; 9.4 The Regulator Can Observe Quality, But Consumers Cannot: Choosing What to Report 9.5 Consumers Can Observe Quality and the Regulator Can Observe "Signals" About Consumers' Types: Risk Adjustment9.6 Concluding Remarks; References; 10 Equity in Health and Health Care in Canada in International Perspective; 10.1 Overview; 10.2 Introduction: Canada's Health Care System and Equity; 10.3 Income-Related Inequity in Access to, and Delivery of, Care; 10.4 Inequalities in Health and Health Outcomes; 10.5 Conclusion and Discussion; References; Index |
| Record Nr. | UNINA-9910830217003321 |
| Weinheim, [Germany] : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Prevention of fetal alcohol spectrum disorder FASD : who is responsible? / / edited by Sterling Clarren, Amy Salmon, and Egon Jonsson
| Prevention of fetal alcohol spectrum disorder FASD : who is responsible? / / edited by Sterling Clarren, Amy Salmon, and Egon Jonsson |
| Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-Blackwell, , c2011 |
| Descrizione fisica | 1 online resource (386 p.) |
| Disciplina | 618.3268 |
| Collana | Health care and disease management |
| Soggetto topico | Fetal alcohol syndrome - Prevention |
| Soggetto genere / forma | Electronic books. |
| ISBN |
3-527-63549-1
3-527-63548-3 1-283-28327-1 9786613283276 3-527-63550-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Prevention of Fetal Alcohol Spectrum Disorder FASD: Who is responsible?; Contents; Preface; List of Contributors; 1: Introduction; 1.1 The Content of This Book; 1.2 What is FASD ?; 1.3 How Common is FASD?; 1.4 What is the Economic Burden of FASD?; 1.4.1 Annual Cost Per Person with FASD; 1.4.2 Comparing Costs; 1.4.3 Cost of Prevention versus Cost of Inaction; 1.5 Approaches to FASD Prevention; 1.5.1 Universal Prevention; 1.5.2 Screening for Prenatal Alcohol Exposure in Obstetric Settings; 1.5.2.1 Meconium Testing; 1.5.2.2 Maternal Self-Reporting; 1.5.3 Selective Prevention
1.5.4 Indicated Prevention1.6 FASD Prevention in A boriginal Communities; 1.7 Main obstacles to Preventing FASD; 1.8 Challenges in Measuring Effectiveness of FASD Prevention Initiatives; 1.9 Who is Responsible for the Prevention of FASD?; References; 2: An Overview of Systematic Reviews on the Prevention, Diagnosis, and Treatment of Fetal Alcohol Spectrum Disorder; 2.1 Introduction; 2.2 Objective and Scope; 2.3 Methodological Approach; 2.3.1 Elements of Assessment; 2.4 Results; 2.4.1 Search Results; 2.4.1.1 Characteristics of Systematic Reviews Included in the Overview 2.4.2 Systematic Reviews on Prevention of FASD and Prenatal Alcohol Use2.4.2.1 General Characteristics; 2.4.2.2 Methodological Characteristics of Systematic Reviews on Prevention of FASD and Prenatal Alcohol Use; 2.4.3 Methodological Quality of Systematic Reviews on Prevention of FASD and Prenatal Alcohol Use; 2.4.3.1 Characteristics of the Evidence Presented in the Systematic Reviews on Prevention Approaches to FASD and Prenatal Alcohol Use; 2.4.3.2 Qualitative Synthesis of the Evidence on the Effectiveness of Prevention Approaches to FASD and Prenatal Alcohol Use 2.4.3.3 Highlights of the Overall Results2.4.4 Systematic Reviews on the Diagnosis of FASD; 2.4.4.1 General Characteristics; 2.4.4.2 Methodological Characteristics of the Systematic Review on Diagnosis of FASD; 2.4.4.3 Methodological Quality of Systematic Reviews on Diagnosis of FASD; 2.4.4.4 Characteristics of the Evidence Presented in the Systematic Review on the Effectiveness of Diagnostic Approaches to FASD; 2.4.4.5 Qualitative Synthesis of the Evidence on the Effectiveness of Diagnostic Approaches to FASD; 2.4.4.6 Highlights of the Overall Results 2.4.5 Systematic Reviews on the Treatment of FASD2.4.5.1 General Characteristics; 2.4.5.2 Methodological Characteristics of Systematic Reviews on Therapeutic Approaches to FASD; 2.4.5.3 Methodological Quality of Systematic Reviews on Therapeutic Approaches to FASD; 2.4.5.4 Characteristics of the Evidence Presented in the Systematic Reviews on Therapeutic Approaches to FASD; 2.4.5.5 Qualitative Synthesis of the Evidence on the Effectiveness of Therapeutic Approaches to FASD; 2.4.5.6 Highlights of the Overall Results; 2.5 Discussion; 2.5.1 FASD Prevention; 2.5.2 FASD Diagnosis 2.5.3 FASD Treatment |
| Record Nr. | UNINA-9910139593203321 |
| Weinheim, Germany : , : Wiley-Blackwell, , c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Prevention of fetal alcohol spectrum disorder FASD : who is responsible? / / edited by Sterling Clarren, Amy Salmon, and Egon Jonsson
| Prevention of fetal alcohol spectrum disorder FASD : who is responsible? / / edited by Sterling Clarren, Amy Salmon, and Egon Jonsson |
| Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-Blackwell, , c2011 |
| Descrizione fisica | 1 online resource (386 p.) |
| Disciplina | 618.3268 |
| Collana | Health care and disease management |
| Soggetto topico | Fetal alcohol syndrome - Prevention |
| ISBN |
3-527-63549-1
3-527-63548-3 1-283-28327-1 9786613283276 3-527-63550-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Prevention of Fetal Alcohol Spectrum Disorder FASD: Who is responsible?; Contents; Preface; List of Contributors; 1: Introduction; 1.1 The Content of This Book; 1.2 What is FASD ?; 1.3 How Common is FASD?; 1.4 What is the Economic Burden of FASD?; 1.4.1 Annual Cost Per Person with FASD; 1.4.2 Comparing Costs; 1.4.3 Cost of Prevention versus Cost of Inaction; 1.5 Approaches to FASD Prevention; 1.5.1 Universal Prevention; 1.5.2 Screening for Prenatal Alcohol Exposure in Obstetric Settings; 1.5.2.1 Meconium Testing; 1.5.2.2 Maternal Self-Reporting; 1.5.3 Selective Prevention
1.5.4 Indicated Prevention1.6 FASD Prevention in A boriginal Communities; 1.7 Main obstacles to Preventing FASD; 1.8 Challenges in Measuring Effectiveness of FASD Prevention Initiatives; 1.9 Who is Responsible for the Prevention of FASD?; References; 2: An Overview of Systematic Reviews on the Prevention, Diagnosis, and Treatment of Fetal Alcohol Spectrum Disorder; 2.1 Introduction; 2.2 Objective and Scope; 2.3 Methodological Approach; 2.3.1 Elements of Assessment; 2.4 Results; 2.4.1 Search Results; 2.4.1.1 Characteristics of Systematic Reviews Included in the Overview 2.4.2 Systematic Reviews on Prevention of FASD and Prenatal Alcohol Use2.4.2.1 General Characteristics; 2.4.2.2 Methodological Characteristics of Systematic Reviews on Prevention of FASD and Prenatal Alcohol Use; 2.4.3 Methodological Quality of Systematic Reviews on Prevention of FASD and Prenatal Alcohol Use; 2.4.3.1 Characteristics of the Evidence Presented in the Systematic Reviews on Prevention Approaches to FASD and Prenatal Alcohol Use; 2.4.3.2 Qualitative Synthesis of the Evidence on the Effectiveness of Prevention Approaches to FASD and Prenatal Alcohol Use 2.4.3.3 Highlights of the Overall Results2.4.4 Systematic Reviews on the Diagnosis of FASD; 2.4.4.1 General Characteristics; 2.4.4.2 Methodological Characteristics of the Systematic Review on Diagnosis of FASD; 2.4.4.3 Methodological Quality of Systematic Reviews on Diagnosis of FASD; 2.4.4.4 Characteristics of the Evidence Presented in the Systematic Review on the Effectiveness of Diagnostic Approaches to FASD; 2.4.4.5 Qualitative Synthesis of the Evidence on the Effectiveness of Diagnostic Approaches to FASD; 2.4.4.6 Highlights of the Overall Results 2.4.5 Systematic Reviews on the Treatment of FASD2.4.5.1 General Characteristics; 2.4.5.2 Methodological Characteristics of Systematic Reviews on Therapeutic Approaches to FASD; 2.4.5.3 Methodological Quality of Systematic Reviews on Therapeutic Approaches to FASD; 2.4.5.4 Characteristics of the Evidence Presented in the Systematic Reviews on Therapeutic Approaches to FASD; 2.4.5.5 Qualitative Synthesis of the Evidence on the Effectiveness of Therapeutic Approaches to FASD; 2.4.5.6 Highlights of the Overall Results; 2.5 Discussion; 2.5.1 FASD Prevention; 2.5.2 FASD Diagnosis 2.5.3 FASD Treatment |
| Record Nr. | UNINA-9910830268203321 |
| Weinheim, Germany : , : Wiley-Blackwell, , c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Prevention of fetal alcohol spectrum disorder FASD : who is responsible? / / edited by Sterling Clarren, Amy Salmon, and Egon Jonsson
| Prevention of fetal alcohol spectrum disorder FASD : who is responsible? / / edited by Sterling Clarren, Amy Salmon, and Egon Jonsson |
| Pubbl/distr/stampa | Weinheim, Germany, : Wiley-Blackwell, c2011 |
| Descrizione fisica | 1 online resource (386 p.) |
| Disciplina | 618.3268 |
| Altri autori (Persone) |
ClarrenSterling
SalmonAmy JonssonEgon |
| Collana | Health care and disease management |
| Soggetto topico | Fetal alcohol spectrum disorders - Prevention |
| ISBN |
9786613283276
9783527635498 3527635491 9783527635481 3527635483 9781283283274 1283283271 9783527635504 3527635505 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Prevention of Fetal Alcohol Spectrum Disorder FASD: Who is responsible?; Contents; Preface; List of Contributors; 1: Introduction; 1.1 The Content of This Book; 1.2 What is FASD ?; 1.3 How Common is FASD?; 1.4 What is the Economic Burden of FASD?; 1.4.1 Annual Cost Per Person with FASD; 1.4.2 Comparing Costs; 1.4.3 Cost of Prevention versus Cost of Inaction; 1.5 Approaches to FASD Prevention; 1.5.1 Universal Prevention; 1.5.2 Screening for Prenatal Alcohol Exposure in Obstetric Settings; 1.5.2.1 Meconium Testing; 1.5.2.2 Maternal Self-Reporting; 1.5.3 Selective Prevention
1.5.4 Indicated Prevention1.6 FASD Prevention in A boriginal Communities; 1.7 Main obstacles to Preventing FASD; 1.8 Challenges in Measuring Effectiveness of FASD Prevention Initiatives; 1.9 Who is Responsible for the Prevention of FASD?; References; 2: An Overview of Systematic Reviews on the Prevention, Diagnosis, and Treatment of Fetal Alcohol Spectrum Disorder; 2.1 Introduction; 2.2 Objective and Scope; 2.3 Methodological Approach; 2.3.1 Elements of Assessment; 2.4 Results; 2.4.1 Search Results; 2.4.1.1 Characteristics of Systematic Reviews Included in the Overview 2.4.2 Systematic Reviews on Prevention of FASD and Prenatal Alcohol Use2.4.2.1 General Characteristics; 2.4.2.2 Methodological Characteristics of Systematic Reviews on Prevention of FASD and Prenatal Alcohol Use; 2.4.3 Methodological Quality of Systematic Reviews on Prevention of FASD and Prenatal Alcohol Use; 2.4.3.1 Characteristics of the Evidence Presented in the Systematic Reviews on Prevention Approaches to FASD and Prenatal Alcohol Use; 2.4.3.2 Qualitative Synthesis of the Evidence on the Effectiveness of Prevention Approaches to FASD and Prenatal Alcohol Use 2.4.3.3 Highlights of the Overall Results2.4.4 Systematic Reviews on the Diagnosis of FASD; 2.4.4.1 General Characteristics; 2.4.4.2 Methodological Characteristics of the Systematic Review on Diagnosis of FASD; 2.4.4.3 Methodological Quality of Systematic Reviews on Diagnosis of FASD; 2.4.4.4 Characteristics of the Evidence Presented in the Systematic Review on the Effectiveness of Diagnostic Approaches to FASD; 2.4.4.5 Qualitative Synthesis of the Evidence on the Effectiveness of Diagnostic Approaches to FASD; 2.4.4.6 Highlights of the Overall Results 2.4.5 Systematic Reviews on the Treatment of FASD2.4.5.1 General Characteristics; 2.4.5.2 Methodological Characteristics of Systematic Reviews on Therapeutic Approaches to FASD; 2.4.5.3 Methodological Quality of Systematic Reviews on Therapeutic Approaches to FASD; 2.4.5.4 Characteristics of the Evidence Presented in the Systematic Reviews on Therapeutic Approaches to FASD; 2.4.5.5 Qualitative Synthesis of the Evidence on the Effectiveness of Therapeutic Approaches to FASD; 2.4.5.6 Highlights of the Overall Results; 2.5 Discussion; 2.5.1 FASD Prevention; 2.5.2 FASD Diagnosis 2.5.3 FASD Treatment |
| Record Nr. | UNINA-9911019348403321 |
| Weinheim, Germany, : Wiley-Blackwell, c2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Treating alcohol and drug abuse [[electronic resource] ] : an evidence based review / / edited by Mats Berglund, Sten Thelander, Egon Jonsson
| Treating alcohol and drug abuse [[electronic resource] ] : an evidence based review / / edited by Mats Berglund, Sten Thelander, Egon Jonsson |
| Pubbl/distr/stampa | Weinheim ; ; Cambridge, : Wiley-VCH, 2003 |
| Descrizione fisica | 1 online resource (653 p.) |
| Disciplina | 362.29 |
| Altri autori (Persone) |
BerglundMats
ThelanderSten JonssonEgon |
| Soggetto topico |
Substance abuse - Treatment
Alcoholism - Treatment |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-52025-6
9786610520251 3-527-60516-9 3-527-60146-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Treating Alcohol and Drug Abuse An Evidence Based Review; Preface; Foreword; Contents; 1 Intervention against Hazardous Alcohol Consumption - Secondary Prevention of Alcohol Problems; 1.1 Introduction; 1.2 Aim; 1.3 Methods; 1.3.1 Selection of Studies, Inclusion and Exclusion Criteria; 1.3.2 Search Strategy; 1.3.3 Outcome Measures; 1.3.4 Rating Scientific Quality; 1.3.5 Analyzing the Results; 1.4 Results; 1.4.1 Literature Search; 1.4.2 Previous Reviews and Meta-Analysis; 1.4.3 Randomized and Controlled Studies; 1.4.4 Studies with Positive Outcome (Measures) Presented in Order of Quality
1.4.5 Studies without Significant Effects, Presented in Order of Quality1.5 Analysis of the Overall Results of the Reviewed Studies; 1.5.1 Studies with a Positive Outcome; 1.5.2 Studies which Showed No Effects; 1.6 Important Aspects of Brief Intervention; 1.6.1 Analysis of Special Groups; 1.7 Problems with Dropout in Studies; 1.8 Problems with Implementation; 1.9 Summary; Glossary; References; 2 Psychosocial Treatment for Alcohol Dependence; 2.1 Introduction; 2.1.1 Earlier Reviews; 2.1.2 Assessing the Effects of Different Methods; 2.1.3 Methodological Deficiencies and Problems 2.1.4 Treatment Methods2.1.5 Treatment Effects; 2.1.6 Questions Addressed; 2.1.7 Intensity and Aftercare; 2.1.8 Subgroups of Alcohol Dependence; 2.2 Method and Material; 2.2.1 Search Strategies; 2.2.2 Result Protocol; 2.2.3 Meta-analysis; 2.3 Results; 2.3.1 Does psychosocial treatment have any effect? Comparisons with no treatment; 2.3.2 Are some methods superior to others?; 2.4 Motivational Methodology; 2.5 Methods Specifically Aimed at Changing the Drinking Problem Itself; 2.5.1 Cognitive Behavioral Therapy (CBT); 2.5.2 Broad Spectrum Treatment with CBT Focus 2.5.3 CRA Treatment - Community Reinforcement Approach2.5.4 Self-control Training; 2.5.5 Cue Exposure; 2.5.6 Other; 2.5.7 Twelve-Step Treatment; 2.6 Methods Aimed at the Factors Behind Alcohol Dependence; 2.6.1 Dynamically Oriented Treatments; 2.7 Standard Treatment; 2.8 Marital Therapies and Interventions Focused on Family Members; 2.9 Studies Showing Matching Results; 2.10 Comparing the Intensity of Treatment and Aftercare; 2.11 Subgroups of Alcohol-Dependent Patients; 2.12 Therapist Factors; 2.13 Gender-related Effects; 2.14 Renewed Literature Search; References 3 Pharmacotherapy for Alcohol Withdrawal Syndrome3.1 Introduction; 3.2 Methods; 3.2.1 Selection Criteria; 3.2.2 Diagnostic Criteria and Outcome Measures; 3.2.3 Search Strategy; 3.2.4 Results; 3.3 Included Studies; 3.3.1 Treatment of Alcohol Withdrawal; 3.3.1.1 Benzodiazepines; 3.3.1.2 Chlormethiazole and Anti-Epileptics; 3.3.1.3 Imidazoline Agonists; 3.3.1.4 Beta-Receptor Antagonists; 3.3.1.5 Nitrous Oxide; 3.3.1.6 Thiamine; 3.3.1.7 Psychological Treatment; 3.3.1.8 Other Treatment; 3.3.1.9 Meta-analyses and Reviews; 3.3.2 Treatment of Delirium Tremens; 3.3.2.1 Barbiturates 3.3.2.2 Benzodiazepines |
| Record Nr. | UNINA-9910146237203321 |
| Weinheim ; ; Cambridge, : Wiley-VCH, 2003 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
